hiv-infections

Documents about hiv-infections

• HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs#852024ClinicalTrials.gov
• Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM#832584ClinicalTrials.gov
• Safety of the EnvPro HIV Vaccine in Healthy Volunteers#837962ClinicalTrials.gov
• Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old#883955ClinicalTrials.gov
• Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men#800977ClinicalTrials.gov
• A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines#172374ClinicalTrials.gov
• Safety and Immunogenicity Study of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adults#261357ClinicalTrials.gov
• A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects#287404ClinicalTrials.gov
• Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP#383620ClinicalTrials.gov
• A Study to Test the Safety of Three Experimental HIV Vaccines#683123ClinicalTrials.gov
• Viracept Expanded Access Program#804039ClinicalTrials.gov
• HIV Self-Testing and Comic Intervention With Refugee Adolescents and Youth#829351ClinicalTrials.gov
• Biomarkers to Predict Time to Plasma HIV RNA Rebound#859943ClinicalTrials.gov
• Anal HPV Infection and Abnormal Cytology in HIV-infected Women#874505ClinicalTrials.gov
• A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects#898155ClinicalTrials.gov
• Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)#843478ClinicalTrials.gov
• Mesalamine to Reduce T Cell Activation in HIV Infection#834812ClinicalTrials.gov
• Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART#844241ClinicalTrials.gov
• HIV-HEART Aging Study#860335ClinicalTrials.gov
• Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants#268073ClinicalTrials.gov
• Lifestyle Modification and Metformin Use in the Treatment of HIV#417523ClinicalTrials.gov
• Evaluating a Combination of Immune-based Therapies to Achieve a Remission of HIV Infection#424221ClinicalTrials.gov
• Analysis of the Nasal Mucosal Immune Response in HIV Infection#837672ClinicalTrials.gov
• Performance and Usability Evaluation of the Atomo HIV Self-Test#881919ClinicalTrials.gov
• Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers#146258ClinicalTrials.gov
• HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)#856739ClinicalTrials.gov
• Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men#861007ClinicalTrials.gov
• A Study of 1592U89 in HIV-Infected Children#865498ClinicalTrials.gov
• Intestinal Protozoal Infections and Sexual Transmitted Diseases Among Targeted Cohorts#868218ClinicalTrials.gov
• Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults#143655ClinicalTrials.gov
• Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems#332791ClinicalTrials.gov
• When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)#353320ClinicalTrials.gov
• Using Mobile Technology and Incentives With Men Who Have Sex With Men and Transgender Women for HIV Prevention#804157ClinicalTrials.gov
• HIV and Changes in the Gut Microbiome After Changes in Antiretroviral Therapy (ART)#826246ClinicalTrials.gov
• Raltegravir as Early Therapy in African-Americans Living With HIV Study#847312ClinicalTrials.gov
• Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)#226329ClinicalTrials.gov
• Effect of HIV/STD Risk Reduction Program on South African Adolescents#300342ClinicalTrials.gov
• "Prime-Boost" Vaccine Schedule for Prevention of HIV Infection#353321ClinicalTrials.gov
• Lipid Profile and Diabetes Mellitus in People With HIV#454100ClinicalTrials.gov
• Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women#459992ClinicalTrials.gov
• Cryptococcal Optimal ART Timing Trial#826673ClinicalTrials.gov
• Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV Patients#860403ClinicalTrials.gov
• Intervention Development for Social Stress, Mental Health, and HIV Risk MSM#884129ClinicalTrials.gov
• A Study of MDL 28,574A in HIV-Infected Patients#889013ClinicalTrials.gov
• Affect Management Intervention for Early Adolescents Wtih Mental Health Problems#900688ClinicalTrials.gov
• Monoclonal Antibody-based Multipurpose Microbicides#905239ClinicalTrials.gov
• Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults#121426ClinicalTrials.gov
• Consolidated guidelines on HIV testing services, 2019: web annex H. Considerations for monitoring HIV testing services programmes#373056WHO IRIS
• Retrovirus Epidemiology Donor Study-II (REDS-II)#851841ClinicalTrials.gov
• A Web-based Intervention Study to Reduce High-risk Sexual Behavior by Persons Living With HIV AIDS (PLWH)#852420ClinicalTrials.gov